Global Sexual Dysfunction Drugs Market Research Report 2023

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.

The global Sexual Dysfunction Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.

This report aims to provide a comprehensive presentation of the global market for Sexual Dysfunction Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexual Dysfunction Drugs.

The Sexual Dysfunction Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Sexual Dysfunction Drugs market comprehensively. Regional market sizes, concerning products by type, by user and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sexual Dysfunction Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by user and by regions.

1.1 Product Overview and Scope of Sexual Dysfunction Drugs

1.2 Sexual Dysfunction Drugs Segment by Type

1.2.1 Global Sexual Dysfunction Drugs Market Value Comparison by Type (2023-2029)

1.2.2 Oral Therapy

1.2.3 Intracavernosal Therapy

1.2.4 Hormonal Therapy

1.2.5 Transurethral Therapy

1.3 Sexual Dysfunction Drugs Segment by User

1.3.1 Global Sexual Dysfunction Drugs Market Value by User: (2023-2029)

1.3.2 Male

1.3.3 Female

1.4 Global Sexual Dysfunction Drugs Market Size Estimates and Forecasts

1.4.1 Global Sexual Dysfunction Drugs Revenue 2018-2029

1.4.2 Global Sexual Dysfunction Drugs Sales 2018-2029

1.4.3 Global Sexual Dysfunction Drugs Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Sexual Dysfunction Drugs Sales Market Share by Manufacturers (2018-2023)

2.2 Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Sexual Dysfunction Drugs Average Price by Manufacturers (2018-2023)

2.4 Global Sexual Dysfunction Drugs Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Sexual Dysfunction Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Sexual Dysfunction Drugs, Product Type & Application

2.7 Sexual Dysfunction Drugs Market Competitive Situation and Trends

2.7.1 Sexual Dysfunction Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Sexual Dysfunction Drugs Players Market Share by Revenue

2.7.3 Global Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Sexual Dysfunction Drugs Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Sexual Dysfunction Drugs Global Sexual Dysfunction Drugs Sales by Region: 2018-2029

3.2.1 Global Sexual Dysfunction Drugs Sales by Region: 2018-2023

3.2.2 Global Sexual Dysfunction Drugs Sales by Region: 2024-2029

3.3 Global Sexual Dysfunction Drugs Global Sexual Dysfunction Drugs Revenue by Region: 2018-2029

3.3.1 Global Sexual Dysfunction Drugs Revenue by Region: 2018-2023

3.3.2 Global Sexual Dysfunction Drugs Revenue by Region: 2024-2029

3.4 North America Sexual Dysfunction Drugs Market Facts & Figures by Country

3.4.1 North America Sexual Dysfunction Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Sexual Dysfunction Drugs Sales by Country (2018-2029)

3.4.3 North America Sexual Dysfunction Drugs Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Sexual Dysfunction Drugs Market Facts & Figures by Country

3.5.1 Europe Sexual Dysfunction Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Sexual Dysfunction Drugs Sales by Country (2018-2029)

3.5.3 Europe Sexual Dysfunction Drugs Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Sexual Dysfunction Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Sexual Dysfunction Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Sexual Dysfunction Drugs Sales by Country (2018-2029)

3.6.3 Asia Pacific Sexual Dysfunction Drugs Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Sexual Dysfunction Drugs Market Facts & Figures by Country

3.7.1 Latin America Sexual Dysfunction Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Sexual Dysfunction Drugs Sales by Country (2018-2029)

3.7.3 Latin America Sexual Dysfunction Drugs Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Sexual Dysfunction Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Sexual Dysfunction Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Sexual Dysfunction Drugs Sales by Country (2018-2029)

3.8.3 Middle East and Africa Sexual Dysfunction Drugs Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Sexual Dysfunction Drugs Sales by Type (2018-2029)

4.1.1 Global Sexual Dysfunction Drugs Sales by Type (2018-2023)

4.1.2 Global Sexual Dysfunction Drugs Sales by Type (2024-2029)

4.1.3 Global Sexual Dysfunction Drugs Sales Market Share by Type (2018-2029)

4.2 Global Sexual Dysfunction Drugs Revenue by Type (2018-2029)

4.2.1 Global Sexual Dysfunction Drugs Revenue by Type (2018-2023)

4.2.2 Global Sexual Dysfunction Drugs Revenue by Type (2024-2029)

4.2.3 Global Sexual Dysfunction Drugs Revenue Market Share by Type (2018-2029)

4.3 Global Sexual Dysfunction Drugs Price by Type (2018-2029)

5.1 Global Sexual Dysfunction Drugs Sales by User (2018-2029)

5.1.1 Global Sexual Dysfunction Drugs Sales by User (2018-2023)

5.1.2 Global Sexual Dysfunction Drugs Sales by User (2024-2029)

5.1.3 Global Sexual Dysfunction Drugs Sales Market Share by User (2018-2029)

5.2 Global Sexual Dysfunction Drugs Revenue by User (2018-2029)

5.2.1 Global Sexual Dysfunction Drugs Revenue by User (2018-2023)

5.2.2 Global Sexual Dysfunction Drugs Revenue by User (2024-2029)

5.2.3 Global Sexual Dysfunction Drugs Revenue Market Share by User (2018-2029)

5.3 Global Sexual Dysfunction Drugs Price by User (2018-2029)

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Pfizer Sexual Dysfunction Drugs Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 GlaxoSmithKline

6.2.1 GlaxoSmithKline Corporation Information

6.2.2 GlaxoSmithKline Description and Business Overview

6.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.2.4 GlaxoSmithKline Sexual Dysfunction Drugs Product Portfolio

6.2.5 GlaxoSmithKline Recent Developments/Updates

6.3 Merck

6.3.1 Merck Corporation Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Merck Sexual Dysfunction Drugs Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Eli Lilly

6.4.1 Eli Lilly Corporation Information

6.4.2 Eli Lilly Description and Business Overview

6.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Eli Lilly Sexual Dysfunction Drugs Product Portfolio

6.4.5 Eli Lilly Recent Developments/Updates

6.5 AbbVie

6.5.1 AbbVie Corporation Information

6.5.2 AbbVie Description and Business Overview

6.5.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.5.4 AbbVie Sexual Dysfunction Drugs Product Portfolio

6.5.5 AbbVie Recent Developments/Updates

6.6 Bayer

6.6.1 Bayer Corporation Information

6.6.2 Bayer Description and Business Overview

6.6.3 Bayer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Bayer Sexual Dysfunction Drugs Product Portfolio

6.6.5 Bayer Recent Developments/Updates

6.7 Teva Pharmaceutical Industries

6.6.1 Teva Pharmaceutical Industries Corporation Information

6.6.2 Teva Pharmaceutical Industries Description and Business Overview

6.6.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Portfolio

6.7.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.8 Takeda

6.8.1 Takeda Corporation Information

6.8.2 Takeda Description and Business Overview

6.8.3 Takeda Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Takeda Sexual Dysfunction Drugs Product Portfolio

6.8.5 Takeda Recent Developments/Updates

6.9 Apricus Biosciences

6.9.1 Apricus Biosciences Corporation Information

6.9.2 Apricus Biosciences Description and Business Overview

6.9.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Apricus Biosciences Sexual Dysfunction Drugs Product Portfolio

6.9.5 Apricus Biosciences Recent Developments/Updates

6.10 Emotional Brain

6.10.1 Emotional Brain Corporation Information

6.10.2 Emotional Brain Description and Business Overview

6.10.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Emotional Brain Sexual Dysfunction Drugs Product Portfolio

6.10.5 Emotional Brain Recent Developments/Updates

6.11 Ivix LLX

6.11.1 Ivix LLX Corporation Information

6.11.2 Ivix LLX Sexual Dysfunction Drugs Description and Business Overview

6.11.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Ivix LLX Sexual Dysfunction Drugs Product Portfolio

6.11.5 Ivix LLX Recent Developments/Updates

6.12 Leadiant Biosciences

6.12.1 Leadiant Biosciences Corporation Information

6.12.2 Leadiant Biosciences Sexual Dysfunction Drugs Description and Business Overview

6.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Leadiant Biosciences Sexual Dysfunction Drugs Product Portfolio

6.12.5 Leadiant Biosciences Recent Developments/Updates

6.13 NexMed

6.13.1 NexMed Corporation Information

6.13.2 NexMed Sexual Dysfunction Drugs Description and Business Overview

6.13.3 NexMed Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.13.4 NexMed Sexual Dysfunction Drugs Product Portfolio

6.13.5 NexMed Recent Developments/Updates

6.14 S1 Biopharma

6.14.1 S1 Biopharma Corporation Information

6.14.2 S1 Biopharma Sexual Dysfunction Drugs Description and Business Overview

6.14.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.14.4 S1 Biopharma Sexual Dysfunction Drugs Product Portfolio

6.14.5 S1 Biopharma Recent Developments/Updates

6.15 Vietstar Biomedical Research

6.15.1 Vietstar Biomedical Research Corporation Information

6.15.2 Vietstar Biomedical Research Sexual Dysfunction Drugs Description and Business Overview

6.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)

6.15.4 Vietstar Biomedical Research Sexual Dysfunction Drugs Product Portfolio

6.15.5 Vietstar Biomedical Research Recent Developments/Updates

7.1 Sexual Dysfunction Drugs Industry Chain Analysis

7.2 Sexual Dysfunction Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Sexual Dysfunction Drugs Production Mode & Process

7.4 Sexual Dysfunction Drugs Sales and Marketing

7.4.1 Sexual Dysfunction Drugs Sales Channels

7.4.2 Sexual Dysfunction Drugs Distributors

7.5 Sexual Dysfunction Drugs Customers

8.1 Sexual Dysfunction Drugs Industry Trends

8.2 Sexual Dysfunction Drugs Market Drivers

8.3 Sexual Dysfunction Drugs Market Challenges

8.4 Sexual Dysfunction Drugs Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Sexual Dysfunction Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Sexual Dysfunction Drugs Market Value Comparison by User (2023-2029) & (US$ Million)

    Table 3. Global Sexual Dysfunction Drugs Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Sexual Dysfunction Drugs Sales (K Pcs) of Key Manufacturers (2018-2023)

    Table 5. Global Sexual Dysfunction Drugs Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Sexual Dysfunction Drugs Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Sexual Dysfunction Drugs Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Sexual Dysfunction Drugs Average Price (USD/Pcs) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Sexual Dysfunction Drugs, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Sexual Dysfunction Drugs, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Sexual Dysfunction Drugs, Product Type & Application

    Table 12. Global Key Manufacturers of Sexual Dysfunction Drugs, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Sexual Dysfunction Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexual Dysfunction Drugs as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Sexual Dysfunction Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Sexual Dysfunction Drugs Sales by Region (2018-2023) & (K Pcs)

    Table 18. Global Sexual Dysfunction Drugs Sales Market Share by Region (2018-2023)

    Table 19. Global Sexual Dysfunction Drugs Sales by Region (2024-2029) & (K Pcs)

    Table 20. Global Sexual Dysfunction Drugs Sales Market Share by Region (2024-2029)

    Table 21. Global Sexual Dysfunction Drugs Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2018-2023)

    Table 23. Global Sexual Dysfunction Drugs Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2024-2029)

    Table 25. North America Sexual Dysfunction Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Sexual Dysfunction Drugs Sales by Country (2018-2023) & (K Pcs)

    Table 27. North America Sexual Dysfunction Drugs Sales by Country (2024-2029) & (K Pcs)

    Table 28. North America Sexual Dysfunction Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Sexual Dysfunction Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Sexual Dysfunction Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Sexual Dysfunction Drugs Sales by Country (2018-2023) & (K Pcs)

    Table 32. Europe Sexual Dysfunction Drugs Sales by Country (2024-2029) & (K Pcs)

    Table 33. Europe Sexual Dysfunction Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Sexual Dysfunction Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Sexual Dysfunction Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Sexual Dysfunction Drugs Sales by Region (2018-2023) & (K Pcs)

    Table 37. Asia Pacific Sexual Dysfunction Drugs Sales by Region (2024-2029) & (K Pcs)

    Table 38. Asia Pacific Sexual Dysfunction Drugs Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Sexual Dysfunction Drugs Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Sexual Dysfunction Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Sexual Dysfunction Drugs Sales by Country (2018-2023) & (K Pcs)

    Table 42. Latin America Sexual Dysfunction Drugs Sales by Country (2024-2029) & (K Pcs)

    Table 43. Latin America Sexual Dysfunction Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Sexual Dysfunction Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Sexual Dysfunction Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Sexual Dysfunction Drugs Sales by Country (2018-2023) & (K Pcs)

    Table 47. Middle East & Africa Sexual Dysfunction Drugs Sales by Country (2024-2029) & (K Pcs)

    Table 48. Middle East & Africa Sexual Dysfunction Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Sexual Dysfunction Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Sexual Dysfunction Drugs Sales (K Pcs) by Type (2018-2023)

    Table 51. Global Sexual Dysfunction Drugs Sales (K Pcs) by Type (2024-2029)

    Table 52. Global Sexual Dysfunction Drugs Sales Market Share by Type (2018-2023)

    Table 53. Global Sexual Dysfunction Drugs Sales Market Share by Type (2024-2029)

    Table 54. Global Sexual Dysfunction Drugs Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Sexual Dysfunction Drugs Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2018-2023)

    Table 57. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2024-2029)

    Table 58. Global Sexual Dysfunction Drugs Price (USD/Pcs) by Type (2018-2023)

    Table 59. Global Sexual Dysfunction Drugs Price (USD/Pcs) by Type (2024-2029)

    Table 60. Global Sexual Dysfunction Drugs Sales (K Pcs) by User (2018-2023)

    Table 61. Global Sexual Dysfunction Drugs Sales (K Pcs) by User (2024-2029)

    Table 62. Global Sexual Dysfunction Drugs Sales Market Share by User (2018-2023)

    Table 63. Global Sexual Dysfunction Drugs Sales Market Share by User (2024-2029)

    Table 64. Global Sexual Dysfunction Drugs Revenue (US$ Million) by User (2018-2023)

    Table 65. Global Sexual Dysfunction Drugs Revenue (US$ Million) by User (2024-2029)

    Table 66. Global Sexual Dysfunction Drugs Revenue Market Share by User (2018-2023)

    Table 67. Global Sexual Dysfunction Drugs Revenue Market Share by User (2024-2029)

    Table 68. Global Sexual Dysfunction Drugs Price (USD/Pcs) by User (2018-2023)

    Table 69. Global Sexual Dysfunction Drugs Price (USD/Pcs) by User (2024-2029)

    Table 70. Pfizer Corporation Information

    Table 71. Pfizer Description and Business Overview

    Table 72. Pfizer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 73. Pfizer Sexual Dysfunction Drugs Product

    Table 74. Pfizer Recent Developments/Updates

    Table 75. GlaxoSmithKline Corporation Information

    Table 76. GlaxoSmithKline Description and Business Overview

    Table 77. GlaxoSmithKline Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 78. GlaxoSmithKline Sexual Dysfunction Drugs Product

    Table 79. GlaxoSmithKline Recent Developments/Updates

    Table 80. Merck Corporation Information

    Table 81. Merck Description and Business Overview

    Table 82. Merck Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 83. Merck Sexual Dysfunction Drugs Product

    Table 84. Merck Recent Developments/Updates

    Table 85. Eli Lilly Corporation Information

    Table 86. Eli Lilly Description and Business Overview

    Table 87. Eli Lilly Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 88. Eli Lilly Sexual Dysfunction Drugs Product

    Table 89. Eli Lilly Recent Developments/Updates

    Table 90. AbbVie Corporation Information

    Table 91. AbbVie Description and Business Overview

    Table 92. AbbVie Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 93. AbbVie Sexual Dysfunction Drugs Product

    Table 94. AbbVie Recent Developments/Updates

    Table 95. Bayer Corporation Information

    Table 96. Bayer Description and Business Overview

    Table 97. Bayer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 98. Bayer Sexual Dysfunction Drugs Product

    Table 99. Bayer Recent Developments/Updates

    Table 100. Teva Pharmaceutical Industries Corporation Information

    Table 101. Teva Pharmaceutical Industries Description and Business Overview

    Table 102. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 103. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product

    Table 104. Teva Pharmaceutical Industries Recent Developments/Updates

    Table 105. Takeda Corporation Information

    Table 106. Takeda Description and Business Overview

    Table 107. Takeda Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 108. Takeda Sexual Dysfunction Drugs Product

    Table 109. Takeda Recent Developments/Updates

    Table 110. Apricus Biosciences Corporation Information

    Table 111. Apricus Biosciences Description and Business Overview

    Table 112. Apricus Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 113. Apricus Biosciences Sexual Dysfunction Drugs Product

    Table 114. Apricus Biosciences Recent Developments/Updates

    Table 115. Emotional Brain Corporation Information

    Table 116. Emotional Brain Description and Business Overview

    Table 117. Emotional Brain Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 118. Emotional Brain Sexual Dysfunction Drugs Product

    Table 119. Emotional Brain Recent Developments/Updates

    Table 120. Ivix LLX Corporation Information

    Table 121. Ivix LLX Description and Business Overview

    Table 122. Ivix LLX Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 123. Ivix LLX Sexual Dysfunction Drugs Product

    Table 124. Ivix LLX Recent Developments/Updates

    Table 125. Leadiant Biosciences Corporation Information

    Table 126. Leadiant Biosciences Description and Business Overview

    Table 127. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 128. Leadiant Biosciences Sexual Dysfunction Drugs Product

    Table 129. Leadiant Biosciences Recent Developments/Updates

    Table 130. NexMed Corporation Information

    Table 131. NexMed Description and Business Overview

    Table 132. NexMed Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 133. NexMed Sexual Dysfunction Drugs Product

    Table 134. NexMed Recent Developments/Updates

    Table 135. S1 Biopharma Corporation Information

    Table 136. S1 Biopharma Description and Business Overview

    Table 137. S1 Biopharma Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 138. S1 Biopharma Sexual Dysfunction Drugs Product

    Table 139. S1 Biopharma Recent Developments/Updates

    Table 140. Vietstar Biomedical Research Corporation Information

    Table 141. Vietstar Biomedical Research Description and Business Overview

    Table 142. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 143. Vietstar Biomedical Research Sexual Dysfunction Drugs Product

    Table 144. Vietstar Biomedical Research Recent Developments/Updates

    Table 145. Key Raw Materials Lists

    Table 146. Raw Materials Key Suppliers Lists

    Table 147. Sexual Dysfunction Drugs Distributors List

    Table 148. Sexual Dysfunction Drugs Customers List

    Table 149. Sexual Dysfunction Drugs Market Trends

    Table 150. Sexual Dysfunction Drugs Market Drivers

    Table 151. Sexual Dysfunction Drugs Market Challenges

    Table 152. Sexual Dysfunction Drugs Market Restraints

    Table 153. Research Programs/Design for This Report

    Table 154. Key Data Information from Secondary Sources

    Table 155. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Sexual Dysfunction Drugs

    Figure 2. Global Sexual Dysfunction Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Sexual Dysfunction Drugs Market Share by Type in 2022 & 2029

    Figure 4. Oral Therapy Product Picture

    Figure 5. Intracavernosal Therapy Product Picture

    Figure 6. Hormonal Therapy Product Picture

    Figure 7. Transurethral Therapy Product Picture

    Figure 8. Global Sexual Dysfunction Drugs Market Value Comparison by User (2023-2029) & (US$ Million)

    Figure 9. Global Sexual Dysfunction Drugs Market Share by User in 2022 & 2029

    Figure 10. Male

    Figure 11. Female

    Figure 12. Global Sexual Dysfunction Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Sexual Dysfunction Drugs Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Sexual Dysfunction Drugs Sales (2018-2029) & (K Pcs)

    Figure 15. Global Sexual Dysfunction Drugs Average Price (USD/Pcs) & (2018-2029)

    Figure 16. Sexual Dysfunction Drugs Report Years Considered

    Figure 17. Sexual Dysfunction Drugs Sales Share by Manufacturers in 2022

    Figure 18. Global Sexual Dysfunction Drugs Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Sexual Dysfunction Drugs Players: Market Share by Revenue in 2022

    Figure 20. Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Sexual Dysfunction Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Sexual Dysfunction Drugs Sales Market Share by Country (2018-2029)

    Figure 23. North America Sexual Dysfunction Drugs Revenue Market Share by Country (2018-2029)

    Figure 24. U.S. Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Sexual Dysfunction Drugs Sales Market Share by Country (2018-2029)

    Figure 27. Europe Sexual Dysfunction Drugs Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Sexual Dysfunction Drugs Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Sexual Dysfunction Drugs Revenue Market Share by Region (2018-2029)

    Figure 35. China Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. China Taiwan Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Latin America Sexual Dysfunction Drugs Sales Market Share by Country (2018-2029)

    Figure 45. Latin America Sexual Dysfunction Drugs Revenue Market Share by Country (2018-2029)

    Figure 46. Mexico Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Brazil Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Argentina Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Sexual Dysfunction Drugs Sales Market Share by Country (2018-2029)

    Figure 50. Middle East & Africa Sexual Dysfunction Drugs Revenue Market Share by Country (2018-2029)

    Figure 51. Turkey Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. UAE Sexual Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Global Sales Market Share of Sexual Dysfunction Drugs by Type (2018-2029)

    Figure 55. Global Revenue Market Share of Sexual Dysfunction Drugs by Type (2018-2029)

    Figure 56. Global Sexual Dysfunction Drugs Price (USD/Pcs) by Type (2018-2029)

    Figure 57. Global Sales Market Share of Sexual Dysfunction Drugs by User (2018-2029)

    Figure 58. Global Revenue Market Share of Sexual Dysfunction Drugs by User (2018-2029)

    Figure 59. Global Sexual Dysfunction Drugs Price (USD/Pcs) by User (2018-2029)

    Figure 60. Sexual Dysfunction Drugs Value Chain

    Figure 61. Sexual Dysfunction Drugs Production Process

    Figure 62. Channels of Distribution (Direct Vs Distribution)

    Figure 63. Distributors Profiles

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed